Haihua Yang

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Squamous Cell Carcinoma

Prostate Cancer

Epidermal Growth Factor Receptor

Top Venues

Life (Basel, Switzerland)

Journal of applied clinical medical physics

Journal of immunology research

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Qianyi Xu, Jiajin Fan, Yevgeniy Vinogradskiy, Ashish K Chawla, Gregory Kubicek, Haihua Yang, Kiet Huynh, Tamara LaCouture, Jimm Grimm, Wei Nie
Feasibility of patient-specific quality assurance (PSQA) for real-time robotic stereotactic body radiotherapy (SBRT) based on tumor motion traces. Journal of applied clinical medical physics 25 (8) (2024)
Qianyi Xu, Jiajin Fan, Yevgeniy Vinogradskiy, Ashish K Chawla, Gregory Kubicek, Haihua Yang, Kiet Huynh, Tamara LaCouture, Jimm Grimm, Wei Nie
Feasibility of patient-specific quality assurance (PSQA) for real-time robotic stereotactic body radiotherapy (SBRT) based on tumor motion traces. Journal of applied clinical medical physics 25 (8) (2024)
Qianyi Xu, Jiajin Fan, Yevgeniy Vinogradskiy, Ashish K Chawla, Gregory Kubicek, Haihua Yang, Kiet Huynh, Tamara LaCouture, Jimm Grimm, Wei Nie
Feasibility of patient-specific quality assurance (PSQA) for real-time robotic stereotactic body radiotherapy (SBRT) based on tumor motion traces. Journal of applied clinical medical physics (2024)
Kuifei Chen, Liqiao Hou, Meng Chen, Shuling Li, Yangyang Shi, William Y Raynor, Haihua Yang
Predicting the Efficacy of SBRT for Lung Cancer with 18 F-FDG PET/CT Radiogenomics. Life (Basel, Switzerland) 13 (4) (2023)
Kuifei Chen, Liqiao Hou, Meng Chen, Shuling Li, Yangyang Shi, William Y Raynor, Haihua Yang
Predicting the Efficacy of SBRT for Lung Cancer with 18 F-FDG PET/CT Radiogenomics. Life (Basel, Switzerland) 13 (4) (2023)
Kuifei Chen, Liqiao Hou, Meng Chen, Shuling Li, Yangyang Shi, William Y Raynor, Haihua Yang
Predicting the Efficacy of SBRT for Lung Cancer with 18 F-FDG PET/CT Radiogenomics. Life (Basel, Switzerland) 13 (4) (2023)
Kuifei Chen, Liqiao Hou, Meng Chen, Shuling Li, Yangyang Shi, William Y Raynor, Haihua Yang
Predicting the Efficacy of SBRT for Lung Cancer with 18 F-FDG PET/CT Radiogenomics. Life (Basel, Switzerland) 13 (4) (2023)
Yangyang Shi, Hailing Xu, William Y Raynor, Jiapei Ding, Ling Lin, Chao Zhou, Wei Wang, Yinnan Meng, Xiaomai Wu, Xiaofeng Chen, Dongqing Lv, Haihua Yang
Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study. Life (Basel, Switzerland) 12 (12) (2022)
Yangyang Shi, Hailing Xu, William Y Raynor, Jiapei Ding, Ling Lin, Chao Zhou, Wei Wang, Yinnan Meng, Xiaomai Wu, Xiaofeng Chen, Dongqing Lv, Haihua Yang
Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study. Life (Basel, Switzerland) 12 (12) (2022)
Songzhe Piao, Lan Zheng, Haihong Zheng, Mengya Zhou, Qin Feng, Suna Zhou, Mang Ke, Haihua Yang, Xuequan Wang
High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration. Journal of immunology research 2022 (2022)
Xuequan Wang, Yinnan Meng, Changxin Liu, Haihua Yang, Suna Zhou
A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma. Journal of oncology 2022 (2022)
Yangyang Shi, Hailing Xu, William Y Raynor, Jiapei Ding, Ling Lin, Chao Zhou, Wei Wang, Yinnan Meng, Xiaomai Wu, Xiaofeng Chen, Dongqing Lv, Haihua Yang
Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study. Life (Basel, Switzerland) 12 (12) (2022)
Xinhang Xia, Wenhu Pi, Yanli Lan, Xiaomai Wu, Dongqing Lv, Yinnan Meng, Haihua Yang, Wei Wang
Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer. Analytical cellular pathology (Amsterdam) 2022 (2022)
Suna Zhou, Yinnan Meng, Xuefeng Sun, Zhicheng Jin, Wei Feng, Haihua Yang
The critical components for effective adaptive radiotherapy in patients with unresectable non-small-cell lung cancer: who, when and how. Future oncology (London, England) (2022)
Shun Lu, Xiaorong Dong, Hong Jian, Jianhua Chen, Gongyan Chen, Yuping Sun, Yinghua Ji, Ziping Wang, Jianhua Shi, Junguo Lu, Shaoshui Chen, Dongqing Lv, Guojun Zhang, Chunling Liu, Juan Li, Xinmin Yu, Zhong Lin, Zhuang Yu, Zhehai Wang, Jiuwei Cui, Xingxiang Xu, Jian Fang, Jifeng Feng, Zhi Xu, Rui Ma, Jie Hu, Nong Yang, Xiangdong Zhou, Xiaohong Wu, Chengping Hu, Zhihong Zhang, You Lu, Yanping Hu, Liyan Jiang, Qi-Ming Wang, Renhua Guo, Jianying Zhou, Baolan Li, Chunhong Hu, Wancheng Tong, Helong Zhang, Lin Ma, Yuan Chen, Zhijun Jie, Yu Yao, Longzhen Zhang, Weng Jie, Weidong Li, Jianping Xiong, Xianwei Ye, Jianchun Duan, Haihua Yang, Meili Sun, Changan Sun, Hongying Wei, Chuan Li, Siraj M Ali, Vincent A Miller, Qiong Wu
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Wei Wang, Meng Chen, Hailing Xu, Dongqing Lv, Suna Zhou, Haihua Yang
USP46 Inhibits Cell Proliferation in Lung Cancer through PHLPP1/AKT Pathway. BioMed research international 2020 (2020)
Yinnan Meng, Haihua Yang, Wei Wang, Xingni Tang, Caiping Jiang, Yichao Shen, Wei Luo
Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients. Radiation oncology (London, England) 14 (1) (2019)